Literature DB >> 3044155

Patterns of in vitro resistance to chloroquine, quinine, and mefloquine of Plasmodium falciparum in Cameroon, 1985-1986.

P Brasseur1, J Kouamouo, O Brandicourt, R Moyou-Somo, P Druilhe.   

Abstract

The drug sensitivity of 246 Plasmodium falciparum isolates was studied in vitro in five areas of Cameroon at the end of 1985. Results demonstrate that parasites resistant either to chloroquine, quinine, or mefloquine, or to two of these drugs, were prevalent in four of the areas investigated, but the drug response pattern varies widely from one area to another. The recent explosive emergence of chloroquine resistance in the south of the country, where both prevalences and levels are very high (up to 86%), contrasts with only moderate levels of resistance in the north. This may be related to differences in transmission by mosquitoes between Sahel and forest areas. Quinine resistance was observed in 24% of the isolates studied in vitro and was frequently associated with chloroquine resistance. The presence of isolates responding poorly to mefloquine, observed mainly in northern Cameroon, suggests that resistance may occur in areas where the drug has never been used.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044155     DOI: 10.4269/ajtmh.1988.39.166

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Antimalarial drug interactions of compounds isolated from Kigelia africana (Bignoniaceae) and their synergism with artemether, against the multidrug-resistant W2mef Plasmodium falciparum strain.

Authors:  Denis Zofou; Mathieu Tene; Pierre Tane; Vincent P K Titanji
Journal:  Parasitol Res       Date:  2011-08-04       Impact factor: 2.289

3.  A primary malarial infection is composed of a very wide range of genetically diverse but related parasites.

Authors:  P Druilhe; P Daubersies; J Patarapotikul; C Gentil; L Chene; T Chongsuphajaisiddhi; S Mellouk; G Langsley
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

4.  Prolonged malaria prophylaxis with chloroquine and proguanil (chloroguanide) in a nonimmune resident population of an endemic area with a high prevalence of chloroquine resistance.

Authors:  D Gozal; C Hengy; G Fadat
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

5.  In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).

Authors:  Mayfong Mayxay; Marion Barends; Alan Brockman; Anchalee Jaidee; Shalini Nair; Dan Sudimack; Tiengkham Pongvongsa; Samlane Phompida; Rattanaxay Phetsouvanh; Tim Anderson; Nicholas J White; Paul N Newton
Journal:  Am J Trop Med Hyg       Date:  2007-02       Impact factor: 2.345

Review 6.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

7.  Randomized control trial of quinine and artesunate in complicated malaria.

Authors:  Anil Kumar Mohanty; B K Rath; R Mohanty; A K Samal; K Mishra
Journal:  Indian J Pediatr       Date:  2004-04       Impact factor: 1.967

8.  Susceptibility of Plasmodium falciparum to different doses of quinine in vivo and to quinine and quinidine in vitro in relation to chloroquine in Liberia.

Authors:  A Björkman; M Willcox; N Marbiah; D Payne
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

9.  Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992-2004).

Authors:  Aline Munier; Aldiouma Diallo; Michel Cot; Ousmane Ndiaye; Pascal Arduin; Jean-Philippe Chippaux
Journal:  Malar J       Date:  2009-04-27       Impact factor: 2.979

10.  Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.

Authors:  Wilfred F Mbacham; Marie-Solange B Evehe; Palmer M Netongo; Isabel A Ateh; Patrice N Mimche; Anthony Ajua; Akindeh M Nji; Domkam Irenee; Justin B Echouffo-Tcheugui; Bantar Tawe; Rachel Hallett; Cally Roper; Geoffrey Targett; Brian Greenwood
Journal:  Malar J       Date:  2010-01-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.